S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q4 2022

RA Capital Management

Period: Q4 2022 Β· Filed: 2023-02-14
View on SEC EDGAR β†—
AUM
$4.93B
Total portfolio value
Positions
70
Reported securities
Top Holding
ASND
17.2% $849.7M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$849.7M17.23%$120.72$274.50+127.4%
17.2%
PCVXVAXCYTE INC$280.9M5.70%$47.20$58.39+23.7%
5.7%
AVTEAEROVATE THERAPEUTICS INC$242.1M4.91%β€”β€”
4.9%
DICEDICE THERAPEUTICS INC$213.7M4.33%β€”β€”
4.3%
VRNAVERONA PHARMA PLC$165.1M3.35%β€”β€”
3.4%
RYTMRHYTHM PHARMACEUTICALS INC$160.6M3.26%$28.64$114.17+298.6%
3.3%
DAWNDAY ONE BIOPHARMACEUTICALS I$151.5M3.07%β€”β€”
3.1%
VORXXXXVOR BIOPHARMA INC$151.3M3.07%β€”β€”
3.1%
BIIBBIOGEN INC$147.6M2.99%$272.63$216.12-20.7%
3.0%
CTKBCYTEK BIOSCIENCES INC$136.6M2.77%$10.12$4.59-54.6%
2.8%
LEGNLEGEND BIOTECH CORP$121.6M2.47%$48.70$29.91-38.6%
2.5%
RNAMAVIDITY BIOSCIENCES INC$121.0M2.45%β€”β€”
2.5%
WVEWAVE LIFE SCIENCES LTD$120.4M2.44%$6.20$6.26+1.0%
2.4%
JANXJANUX THERAPEUTICS INC$114.2M2.32%$14.02$15.54+10.8%
2.3%
ETNB89BIO INC$114.0M2.31%β€”β€”
2.3%
PEPGPEPGEN INC$108.7M2.21%$13.33$1.76-86.8%
2.2%
IMGNIMMUNOGEN INC$108.4M2.20%β€”β€”
2.2%
BLUBELLUS HEALTH INC NEW$102.4M2.08%β€”β€”
2.1%
INBXINHIBRX INC$95.0M1.93%β€”$97.58
1.9%
CLDXCELLDEX THERAPEUTICS INC NEW$92.5M1.88%$43.39$38.37-11.6%
1.9%
ITOSITEOS THERAPEUTICS INC$86.3M1.75%β€”β€”
1.8%
TVTXTRAVERE THERAPEUTICS INC$83.8M1.70%$20.66$56.92+175.5%
1.7%
COGTCOGENT COMMUNICATIONS HLDGS$69.3M1.41%$11.07$38.69+249.5%
1.4%
ACRSACLARIS THERAPEUTICS INC$69.3M1.40%$15.07$5.56-63.1%
1.4%
FULCFULCRUM THERAPEUTICS INC$69.2M1.40%$7.90$3.84-51.4%
1.4%
ACRVACRIVON THERAPEUTICS INC$55.4M1.12%$11.57$1.72-85.1%
1.1%
TYRATYRA BIOSCIENCES INC$55.0M1.12%$7.07$30.62+333.1%
1.1%
ABOSACUMEN PHARMACEUTICALS INC$52.8M1.07%$5.26$2.74-47.9%
1.1%
AKROAKERO THERAPEUTICS INC$52.5M1.07%β€”β€”
1.1%
CLYMELIEM THERAPEUTICS INC$48.3M0.98%$3.31$12.90+289.7%
1.0%

Quarter-on-Quarter Activity

Q4 2022 vs. Q3 2022

New Positions (8)

TickerIssuerNotionalSince Filing
INBXINHIBRX INC$95.0M
ACRVACRIVON THERAPEUTICS INC$55.4M-85.1%
NAMSNEWAMSTERDAM PHARMA COMPANY$43.6M
SPRYARS PHARMACEUTICALS INC$25.7M
CELCCELCUITY INC$19.6M
SLDBSOLID BIOSCIENCES INC$18.4M
SCPHSCPHARMACEUTICALS INC$13.3M
IMRAIMARA INC$13.3M

Exited Positions (8)

TickerIssuerNotional
FMTXFORMA THERAPEUTICS HLDGS INC$179.8M
RLMDRELMADA THERAPEUTICS INC$74.0M
ENTAENANTA PHARMACEUTICALS INC$46.5M
TILINSTIL BIO INC$37.1M
VERAVERA THERAPEUTICS INC$33.6M
ACETADICET BIO INC$29.3M
MISTMILESTONE PHARMACEUTICALS IN$20.6M
PMVPPMV PHARMACEUTICALS INC$20.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
TNYATENAYA THERAPEUTICS INC$7.5M+278.7%
RNAMAVIDITY BIOSCIENCES INC$85.6M+151.7%
VORXXXXVOR BIOPHARMA INC$107.0M+104.6%
COGTCOGENT COMMUNICATIONS HLDGS$9.5M+49.5%+249.5%
FULCFULCRUM THERAPEUTICS INC$12.6M+35.8%-51.4%
DICEDICE THERAPEUTICS INC$108.0M+31.5%
PCVXVAXCYTE INC$170.9M+27.9%+23.7%
ETNB89BIO INC$68.9M+15.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
NSTGQNANOSTRING TECHNOLOGIES$-57.6M-96.9%
ENTXENTERA BIO LTD$-1.9M-85.8%
THRDTHIRD HARMONIC BIO INC$-63.6M-84.6%
ACHLACHILLES THERAPEUTICS PLC$-9.9M-67.9%
GERNGERON CORP$-39.2M-57.1%
DBVTDBV TECHNOLOGIES S A$-3.6M-47.4%
BIIBBIOGEN INC$-102.8M-43.2%-20.7%
IOBTQIO BIOTECH INC$-2.4M-39.3%
← Back to Hedge Funds